Skip to content

Efficacy of Pain Neuroscience Education in Genito-Pelvic Pain/Penetration Disorder. A Randomized Controlled Trial.

Educational Program Interventions for Patients Suffering From Persistent Pelvic Pain and Their Effects Over Pain and Functionality. A Multi-centered Randomized Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05114473
Enrollment
69
Registered
2021-11-10
Start date
2021-12-10
Completion date
2022-03-21
Last updated
2025-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Dysfunction Sexual

Brief summary

Patients suffering pelvic persistent pain deal with significant pain that affects their quality of life. Often, conservative treatment interventions are scarce for these patients and are therefore not considered. Education has been developed as a relevant tool in the treatment of patients who suffer from chronic pain or any other pain processing alterations, and has the potential to become a powerfull treatment alternative.

Detailed description

In this intervention, the effects of implementing educational programs in patients suffering from pelvic persistent pain will be assessed. Patients with pelvic persistent pain have both problems directly related with their pain and other issues that appear derived from suffering pain over a determined period, such as alterations in the sexuality or overall quality of life. Facing these patients is a challenge for professionals, and many can't find the treatment that properly fits the patient's clinical presentation. Education, and educating patients on their problem, is an exponentially growing alternative used in Physical Therapy involving patients who suffer from a dysfunctional pain, chronic pain, or any kind of pain presentation that affects the patient's well-being. This study will assess firstly if the implementation of a pain-related education program is relevant in the treatment of pelvic persistent pain, and will further observe which modality (presential workshops or online-accessed material) is the most effective involving adherence and improvement.

Interventions

Several face-to-face workshops given by a researcher

Access to a website containing the educational program

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Masking description

Due to the nature of the intervention, participants can't be blinded to allocation, but are strongly inculcated not to disclose the allocation their status at the follow up assessments. Care providers will be different from outcome assessors and will be both blinded by an external investigator.

Intervention model description

Two groups receiving intervention and one serving as control

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years-old suffering from dyspareunia for more than 3 months

Exclusion criteria

* Patients suffering from a previous medical condition that explains logically the presence of pain

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue ScaleBaseline to week 4Pain intensity assessment instrument. Minimum value 0, maximum value 10. Higher scores mean worse outcome

Secondary

MeasureTime frameDescription
Pain Catastrophizing ScaleBaseline to week 4Instrument developed quantify an individual's pain experience. Minimum value 0, maximum value 52. Higher scores mean worse outcome
Survey of Pain AttitudesBaseline to week 4Instrument to understand the pain-related beliefs of your chronic pain patients. Minimum value 0, maximum value 285. Higher scores mean better results
Female Sexual Function IndexBaseline to week 4Inventory designed to assess female sexual function. Minimum value 2, maximum value 36. Higher scores mean better functioning

Countries

Spain

Participant flow

Participants by arm

ArmCount
Workshops
This group will attend face-to-face workshops were the educational program will be developed. These workshops will be available in several sites, and specific care providers will be assigned for each of these sites. Workshops: Several face-to-face workshops given by a researcher
18
Online-accessed Material
This group will be granted online access to a platform were the educational program will be uploaded. They will be given autonomy regarding when to enter the platform and view the content. Online-accessed material: Access to a website containing the educational program
29
Control Group
This group will initially no recieve an intervention and will serve as a control group.
22
Total69

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up220

Baseline characteristics

CharacteristicWorkshopsOnline-accessed MaterialControl GroupTotal
Age, Continuous34.5 years
STANDARD_DEVIATION 13.2
31.6 years
STANDARD_DEVIATION 6.9
33.0 years
STANDARD_DEVIATION 9.1
32.8 years
STANDARD_DEVIATION 9.5
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
18 Participants29 Participants22 Participants69 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 0
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Visual Analogue Scale

Pain intensity assessment instrument. Minimum value 0, maximum value 10. Higher scores mean worse outcome

Time frame: Baseline to week 4

ArmMeasureGroupValue (MEAN)Dispersion
WorkshopsVisual Analogue ScalePre5.3 score on a scaleStandard Deviation 2.5
WorkshopsVisual Analogue ScalePost3.8 score on a scaleStandard Deviation 2.4
Online-accessed MaterialVisual Analogue ScalePre5.8 score on a scaleStandard Deviation 2
Online-accessed MaterialVisual Analogue ScalePost4.9 score on a scaleStandard Deviation 2.5
Control GroupVisual Analogue ScalePre5.1 score on a scaleStandard Deviation 1.8
Control GroupVisual Analogue ScalePost4.9 score on a scaleStandard Deviation 2.2
Secondary

Female Sexual Function Index

Inventory designed to assess female sexual function. Minimum value 2, maximum value 36. Higher scores mean better functioning

Time frame: Baseline to week 4

ArmMeasureGroupValue (MEAN)Dispersion
WorkshopsFemale Sexual Function IndexPre18.9 score on a scaleStandard Deviation 7.8
WorkshopsFemale Sexual Function IndexPost21.0 score on a scaleStandard Deviation 9.5
Online-accessed MaterialFemale Sexual Function IndexPre19.1 score on a scaleStandard Deviation 7.3
Online-accessed MaterialFemale Sexual Function IndexPost20.8 score on a scaleStandard Deviation 8.1
Control GroupFemale Sexual Function IndexPre19.5 score on a scaleStandard Deviation 7.1
Control GroupFemale Sexual Function IndexPost18.4 score on a scaleStandard Deviation 9.3
Secondary

Pain Catastrophizing Scale

Instrument developed quantify an individual's pain experience. Minimum value 0, maximum value 52. Higher scores mean worse outcome

Time frame: Baseline to week 4

ArmMeasureGroupValue (MEAN)Dispersion
WorkshopsPain Catastrophizing ScalePre25.2 score on a scaleStandard Deviation 12.7
WorkshopsPain Catastrophizing ScalePost18.9 score on a scaleStandard Deviation 12.6
Online-accessed MaterialPain Catastrophizing ScalePre28.0 score on a scaleStandard Deviation 10.4
Online-accessed MaterialPain Catastrophizing ScalePost20.4 score on a scaleStandard Deviation 11.5
Control GroupPain Catastrophizing ScalePre22.4 score on a scaleStandard Deviation 7.5
Control GroupPain Catastrophizing ScalePost25.3 score on a scaleStandard Deviation 8.2
Secondary

Survey of Pain Attitudes

Instrument to understand the pain-related beliefs of your chronic pain patients. Minimum value 0, maximum value 285. Higher scores mean better results

Time frame: Baseline to week 4

ArmMeasureGroupValue (MEAN)Dispersion
WorkshopsSurvey of Pain AttitudesPre45.1 score on a scaleStandard Deviation 10.6
WorkshopsSurvey of Pain AttitudesPost45.2 score on a scaleStandard Deviation 14.5
Online-accessed MaterialSurvey of Pain AttitudesPre49.6 score on a scaleStandard Deviation 13.1
Online-accessed MaterialSurvey of Pain AttitudesPost50.9 score on a scaleStandard Deviation 14.8
Control GroupSurvey of Pain AttitudesPre52.4 score on a scaleStandard Deviation 13
Control GroupSurvey of Pain AttitudesPost52.4 score on a scaleStandard Deviation 13.6

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026